DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 36 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $755,000 | +72.0% | 37,460 | +88.2% | 0.05% | +80.0% |
| Q4 2020 | $439,000 | +106.1% | 19,905 | +105.5% | 0.03% | +130.8% |
| Q4 2019 | $213,000 | +147.7% | 9,688 | -61.7% | 0.01% | +160.0% |
| Q1 2017 | $86,000 | +2.4% | 25,300 | -13.7% | 0.01% | -16.7% |
| Q4 2016 | $84,000 | -43.2% | 29,300 | +16.3% | 0.01% | -33.3% |
| Q3 2016 | $148,000 | -37.0% | 25,200 | +27.1% | 0.01% | -71.9% |
| Q4 2015 | $235,000 | -34.4% | 19,833 | -54.5% | 0.03% | +300.0% |
| Q3 2015 | $358,000 | -55.4% | 43,555 | -24.3% | 0.01% | -61.9% |
| Q2 2015 | $803,000 | +150.9% | 57,574 | +332.9% | 0.02% | +162.5% |
| Q1 2015 | $320,000 | – | 13,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,705,392 | $43,607,000 | 7.88% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $78,762,000 | 4.46% |
| DAFNA Capital Management LLC | 587,756 | $15,029,000 | 3.57% |
| RTW INVESTMENTS, LP | 7,463,291 | $190,836,000 | 2.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $5,114,000 | 2.79% |
| Evolutionary Tree Capital Management, LLC | 122,473 | $3,132,000 | 1.85% |
| Parkman Healthcare Partners LLC | 303,268 | $7,755,000 | 1.80% |
| Eagle Health Investments LP | 161,125 | $4,120,000 | 1.62% |
| BRIDGER MANAGEMENT, LLC | 588,910 | $15,058,000 | 1.41% |
| Woodline Partners LP | 1,777,000 | $45,438,000 | 1.01% |